Cytokinetics, Incorporated (CYTK)
NASDAQ·Healthcare·Biotechnology
$65.90
-2.51%
Mkt Cap $8.56B
Analyst Ratings
Buy
18
Hold
0
Sell
0
Price Target (51 analysts)
$107.80
Range $84.00 – $140.00
Implied Upside
+63.6%
Consensus $107.80 vs current $65.90
NASDAQ·Healthcare·Biotechnology
$65.90
-2.51%
Mkt Cap $8.56B
Buy
18
Hold
0
Sell
0
Price Target (51 analysts)
$107.80
Range $84.00 – $140.00
+63.6%
Consensus $107.80 vs current $65.90